Fate Therapeutics, Inc. (FATE) Earnings
NASDAQ·Healthcare·Biotechnology
$2.37
+1.94%
Mkt Cap $280.91M
EPS — Estimate vs Actual
Mkt Cap
$280.91M
P/E
—
Fwd P/E
—
P/S
44.48
Rev TTM
—
EPS TTM
-$1.09
NASDAQ·Healthcare·Biotechnology
$2.37
+1.94%
Mkt Cap $280.91M
Mkt Cap
$280.91M
P/E
—
Fwd P/E
—
P/S
44.48
Rev TTM
—
EPS TTM
-$1.09